Dear all,Back to the Top
When changing a formulation, from capsule to tablet, during drug
development, should we assess bioequivalence or only relative
Moreover, can we extrapolate DMT value obtained from the first
formulation to the DMT with the second formulation from the relative
With thanks in advance.
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (firstname.lastname@example.org)